Incontinence article with ph regulator

ZA202205793BActive Publication Date: 2026-10-28PAUL HARTMANN AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ZA202205793
Authority / Receiving Office
ZA · ZA
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-12-20
Filing Date
2022-05-25
Publication Date
2026-10-28
Estimated Expiration
2040-12-18

AI Technical Summary

Technical Problem

Incontinence articles often cause skin irritation due to prolonged contact with bodily excretions, particularly urine, leading to incontinence-associated dermatitis, and existing pH-regulating agents like citric acid and sodium citrate are difficult to produce homogeneously, resulting in uneven distribution and potential skin irritation.

Method used

Incorporating a pH regulator comprising monosodium citrate or disodium citrate, which are less hygroscopic and easier to dose, to maintain a uniform pH value and prevent acidic reactions, with particle sizes of 10-2000 μm for prolonged buffering effect and improved manufacturing efficiency.

Benefits of technology

The use of monosodium citrate or disodium citrate in incontinence articles maintains a skin-friendly pH over multiple micturition events, reducing skin irritation and manufacturing complexities, while ensuring consistent buffering without acidic reactions.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to an incontinence article for receiving bodily excretions, comprising a topsheet at least portions of which are liquid-permeable, a substantially liquid-impermeable backsheet and an absorption body arranged between the topsheet and the backsheet, and at least portions of the incontinence article comprising a pH regulator between the topsheet and the backsheet, characterized in that the pH regulator contains monosodium citrate or disodium citrate.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Title: Incontinence products with pH regulator

[0002] Description

[0003] The present invention relates to an incontinence product for the absorption of bodily excretions with a means for regulating the pH value for the preferred use by adults, and arrangements of such incontinence products.

[0004] A common problem with the continued use of incontinence products is the development of skin irritation or inflammation caused by prolonged contact of the skin with bodily fluids such as urine. Incontinence-associated dermatitis (IAD), a skin inflammation in the perineal or perigenital region caused by contact with an irritant such as urine, is particularly common in older incontinent individuals. Changes in the skin's pH level upon contact with the more alkaline urine play a significant role in this condition. The increased incidence of IAD in older adults correlates with a weakened skin barrier and a reduced ability of the skin to regenerate. Furthermore, individuals suffering from incontinence due to medical or age-related reasons often require assistance from caregivers.Especially at night, the need for an undisturbed night's sleep conflicts with the regular checking and prompt changing of incontinence products after urination. Therefore, prolonged contact between the skin and bodily fluids is common during this time. For individuals experiencing frequent urination, it would improve their quality of life and reduce costs if incontinence products did not need to be changed immediately after each urination.

[0005] Therefore, especially in cases of high urination frequency or longer change intervals, there is a need for incontinence products with improved skin compatibility.

[0006] Incontinence products for adults have been known for a long time and often feature a top sheet that is at least partially permeable to liquid, a back sheet that is essentially impermeable to liquid, and an absorbent core positioned between the top sheet and the back sheet. These products can be designed in a variety of ways, for example, as incontinence products that lie directly against the body or as absorbent incontinence pads.

[0007] Prior art includes approaches to supplying incontinence products with a pH-control agent. WO2012121932A1 teaches the use of a buffer solution comprising a weak acid or a weak base and the corresponding salt, such as citric acid and sodium citrate in a specific ratio. In general technical terminology, sodium citrate refers to the tribasic sodium salt of citric acid, also known as trisodium citrate.

[0008] The inventors recognized that using a buffer mixture of citric acid and sodium citrate has the disadvantage that producing a homogeneous mixture is technically complex and that at least partial segregation and uneven distribution of the individual components can easily occur during the production process. This can lead to faulty and non-compliant incorporation of the components into incontinence products, which are typically manufactured on high-speed production machines. Consequently, there is a risk that the quantity and / or distribution of the components in the buffer mixture—and thus the assurance of the desired buffering effect during intended use of the products—is subject to significant variations between individual incontinence products or within a single incontinence product.The risk of local accumulation of citric acid results in the pH value of the incontinence product in this area becoming highly acidic, meaning that the pH value in this area drops significantly below a value that is beneficial to the health of the skin.

[0009] The present invention is therefore based on the objective of overcoming these disadvantages.

[0010] Another objective of the invention is to provide users with different needs with incontinence products that are more skin-friendly.

[0011] This problem is solved by an incontinence product for the absorption of bodily excretions, comprising a topsheet that is at least partially permeable to liquid, a backsheet that is essentially impermeable to liquid, and an absorbent core arranged between the topsheet and the backsheet, wherein the incontinence product comprises a pH regulator at least partially between the topsheet and the backsheet, characterized in that the pH regulator comprises monosodium citrate or disodium citrate. Therefore, the pH regulator can preferably comprise either monosodium citrate or disodium citrate, or monosodium citrate and disodium citrate.

[0012] The incontinence product according to the invention allows a relatively consistent pH value to be maintained over several urination events. A further advantage of using monosodium citrate is, for example, that it is less hygroscopic than citric acid, thus preventing unwanted moisture from entering the incontinence product before use. Since monosodium citrate is less hygroscopic than citric acid, it also offers the advantage of better flowability, making it easier to dose.

[0013] The backsheet can be made of a breathable, but essentially liquid-tight, film material. The topsheet is preferably made, at least in some areas, of a non-woven material that is at least partially liquid-permeable.

[0014] In a preferred embodiment, the pH regulator additionally comprises trisodium citrate; thus, the pH regulator can preferably comprise either monosodium citrate and trisodium citrate, or disodium citrate and trisodium citrate, or monosodium citrate, disodium citrate, and trisodium citrate. This allows for fine-tuning of the buffering effect of an incontinence product depending on the desired duration of use or absorption capacity of the product, without the risk of developing highly acidic areas, as can occur when using citric acid.

[0015] Preferably, the pH regulator in such a case has a homogeneous mixture of the respective citrates. This has the advantage that local differences in the buffering capacity of the pH regulator can be avoided.

[0016] The terms monosodium citrate, disodium citrate, and trisodium citrate encompass both the non-hydrogenated form and the hydrates of the respective substances. In a preferred embodiment, the pH regulator consists of monosodium citrate.

[0017] In another preferred embodiment, the pH regulator consists of disodium citrate.

[0018] Using only one component as a pH regulator offers process advantages, as there is no need to mix different components or maintain a homogeneous mixture during the manufacturing process. Furthermore, it promotes a uniform buffering effect across the areas of the incontinence product containing the pH regulator.

[0019] It has proven advantageous if the pH regulator is in particulate form.

[0020] Preferably, at least 50% by weight of the pH regulator has a particle size of 10 to 2000 pm, in particular of 50 to 1200 pm, and further in particular of 80 to 800 pm.

[0021] In principle, pH regulators with smaller or larger particle sizes are also available and usable.

[0022] However, the preferred particle sizes offer the advantage that particles of such a size dissolve more slowly when wetted with bodily excretions such as urinary fluid than pH regulators of smaller particle size, so that the pH regulator is not washed out as quickly during use and a pH-regulating effect is maintained for longer on the upper side of the incontinence product facing the user's skin.

[0023] Furthermore, a pH regulator of the preferred particle size is easier to dose and incorporate into the incontinence product, especially in fast-running machines, than, for example, finely powdered pH regulators, because there is less dust generation and associated material loss in the manufacturing process.

[0024] On the other hand, particles of this size also offer the advantage that they are less noticeable to the touch during use of the incontinence product than, for example, granules with a larger particle size, thus improving the wearing comfort of the incontinence product.

[0025] As an alternative to particulate pH regulator, the pH regulator can also be introduced into the incontinence product in dissolved form, in particular as an aqueous or alcoholic solution, especially by spraying or immersion and optionally subsequent drying of at least one absorbent layer.

[0026] As a further alternative, an additional, particularly sheet-like material, especially nonwoven or cellulose material, pretreated with the pH-regulating agent, can be included in the incontinence product. Preferably, such a sheet-like material can be arranged between the fluid-absorbing layer and a storage layer of the absorbent core.

[0027] In a preferred embodiment, the amount of pH regulator is 10 to 100 g / m³. 2 , especially 20 to 80 g / m² 2 , furthermore, in particular 25 to 60 g / m² 2The amount of pH regulator is based on the area of ​​the flat incontinence product covered by the pH regulator. The above quantity of pH regulator refers to an anhydrous pH regulator, for example, non-hydrogenated monosodium citrate. If the pH regulator contains one or more hydrates or, as described below, more than 5%, and in particular more than 10%, additive substances, the total amount of pH regulator is given in g / m². 2 such that the total amount of the contained pure and / or non-hydrogenated pH regulator corresponds to the aforementioned preferred amount.

[0028] Preferably, monosodium citrate, disodium citrate, or trisodium citrate is used in essentially pure form, particularly with a purity level of at least 90%, further particularly at least 95%, further particularly at least 98%, further particularly at least 99%, further particularly at least 100%. This largely prevents skin irritation caused by residues of other substances when using the incontinence product.

[0029] However, it is also conceivable that the pH regulator contains a small amount of one or more additive substances, for example, finishing and / or conditioning agents such as release agents, stabilizers, dust suppressants, anti-caking agents, wetting agents, coagulants, anticoagulants, adhesive or surfactant substances, antimicrobial substances, dyes or fragrances, or pH indicators. In such cases, the proportion of one or more other substances in the total amount of the pH regulator is preferably less than 10%, more preferably less than 5%, more preferably less than 2%, and more preferably less than 1%. The absorbent core of the incontinence product is suitable and intended to absorb and permanently store bodily excretions, in particular body fluids, especially urine.

[0030] The absorption body advantageously comprises at least one storage layer, which preferably has a superabsorbent polymer (SAP).

[0031] Alternatively, the absorption body can also comprise more than one, in particular at least two, storage layers.

[0032] The absorption body can comprise one or more channels in one or more storage layers.

[0033] The absorption body can be rectangular, triangular, oval, T-shaped, hourglass-shaped, asymmetrical or in any other shape that may appear suitable to a person skilled in the art.

[0034] In a preferred embodiment, the absorbent body contains superabsorbent polymer material (SAP) in the amount of 5–100% by weight, preferably 10–95% by weight, more preferably 15–90% by weight, and most preferably 20–80% by weight. Typically, the SAP material can absorb at least 15 times, and in particular 20 times, its weight in 0.9% by weight saline solution (measured according to NWSP 242.0. R2(15)).

[0035] The SAP material can be, for example, particle-shaped, fibrous, sheet-shaped, or foam-shaped.

[0036] The storage layer of the absorption body can contain other materials, such as cellulose fibers ("fluff") or plastic fibers. It is also conceivable to form the storage layer of the absorption body by arranging one or more layers of different materials, particularly nonwoven fabrics.

[0037] According to a preferred embodiment, the storage layer is essentially free of the pH regulator.

[0038] Essentially free of pH regulators means that the respective layer of the absorbent body, in particular the storage layer, contains less than 10 g / m². 2 , especially less than 7 g / m² 2 , especially less than 5 g / m² 2 , especially less than 2 g / m² 2 pH regulator, and in particular does not contain a pH regulator. This advantageously avoids any possible impairment of the function of the respective layer, especially the storage layer, and in particular of the SAP material preferably contained in the storage layer.

[0039] It is further preferred that the layer of the absorbent core directly facing the backsheet is essentially free of the pH regulator. This advantageously results in greater wearing comfort, particularly with incontinence products worn close to the body, as the backsheet side provides a softer tactile feel. It is also known to those skilled in the art that particulate material can exert abrasive forces that can damage the essentially liquid-impermeable backsheet, especially a liquid-impermeable backsheet film of the absorbent product, and lead to leakage of the product.A layer that is essentially free of pH regulators, especially particulate pH regulators, and directly facing the backsheet, therefore has the advantage of reducing the risk of damage to the backsheet film during the manufacturing process or during use of the incontinence product.

[0040] Furthermore, it proves advantageous if the incontinence product includes a fluid absorption layer that forms a layer of the absorbent core directly facing the topsheet. This allows the amount of fluid produced during a voiding event to be quickly absorbed, distributed, and transferred to the at least one storage layer.

[0041] Layers for the rapid absorption and distribution of bodily excretions, so-called fluid absorption or distribution layers, are already known in the field and typically consist of a fibrous material, in particular a nonwoven material.

[0042] The fibers can be of natural or artificial origin and can be of a defined length (staple fibers), continuous ("endless"), or formed in situ. The fibers can be made from a single polymer or a polymer mixture (single-component fiber) or from more than one polymer and / or a polymer mixture (multi-component fiber).

[0043] A multi-component fiber has a cross-section comprising more than one single section, each of which comprises a different polymer or polymer blend. The term multi-component fiber includes, but is not limited to, a two-component fiber. The different components of multi-component fibers are arranged in substantially distinct regions across the fiber's cross-section and extend continuously along its length. A multi-component fiber may have an overall cross-section that includes sub-regions of the two or more different components of any shape or arrangement, including, for example, coaxial sub-sections, core and sheath sub-sections, adjacent sub-sections, radial sub-sections, island sub-sections, etc.

[0044] A two-component fiber with a "core / sheath structure" has a cross-section comprising: two discrete sections, each consisting of a polymer or polymer mixture, wherein the sheath polymer or sheath polymer mixture component is arranged around the core polymer or core polymer mixture component.

[0045] The basis weight of nonwoven materials is usually given in grams per square meter (g / m²). 2 ).

[0046] In a preferred embodiment, the liquid absorption layer comprises multi-component fibers, in particular two-component fibers, and further, in particular, two-component fibers containing polyester, so-called Bico / PES fibers. The multi-component fibers, in particular the two-component fibers, preferably have a circular or three-lobed cross-section.

[0047] Preferred combinations of components in two-component fibers are polyethylene terephthalate (PET) / polyethylene (PE), PET / polypropylene (PP), PET / polyester copolymers (CoPET), polylactic acid (PLA) / polylactide copolymers (COPLA), PLA / PE and PLA / PP.

[0048] As an alternative, it is known in the field to use a material made of chemically modified cellulose fibers, for example cross-linked cellulose fibers, as a liquid absorption layer.

[0049] The liquid absorption layer may also include or consist of other materials such as perforated films or foams or the like.

[0050] The fluid absorption layer can substantially completely or only partially cover the at least one storage layer of the absorbent body, thus having substantially the same surface area or at least a partially smaller area than the at least one storage layer and / or the layer of the absorbent body directly facing the backsheet in the longitudinal and / or transverse direction of the flat-lying incontinence product. Preferably, the fluid absorption layer covers the at least one storage layer and / or the layer of the absorbent body directly facing the backsheet by 5-100%, particularly by 10-90%, further particularly by 15-80%, and further particularly by 20-70% of its surface area.

[0051] Preferably, the fluid-absorbing layer is arranged at least in an area where the urinary fluid comes into contact with the incontinence product during use. In particular, the fluid-absorbing layer extends over and within a transverse central axis of the absorbent body.

[0052] In a preferred embodiment, the pH regulator is positioned essentially between the liquid-absorbing layer and an absorbent layer facing the backsheet. In particular, at least 70% by weight, more specifically 80% by weight, more specifically at least 90% by weight, and more specifically at least 95% by weight of the pH regulator are positioned between the liquid-absorbing layer and the absorbent layer facing the backsheet.

[0053] Preferably, the pH regulator does not touch the topsheet when the incontinence product is dry; in particular, at least 70% by weight, more specifically 80% by weight, more specifically at least 90% by weight, more specifically at least 95% by weight of the pH regulator is positioned between a layer of the absorbent body facing the topsheet, in particular the fluid absorption layer, and the layer of the absorbent body closest to the backsheet.

[0054] This advantageously results in the pH regulator being arranged on the upper side of the fluid absorption layer or other absorbent layer facing away from the user's skin when the incontinence product is used, and in particular is not in direct contact with the user's skin.

[0055] Alternatively, the pH regulator can be positioned essentially between a top surface of the liquid absorption layer facing the topsheet and the absorbent layer facing the backsheet, in particular essentially within the liquid absorption layer.

[0056] It is advantageous if the pH value on the upper surface of the incontinence product facing the skin is 4.8–6.5, particularly 5.0–6.2, more particularly 5.2–6.0, more particularly 5.3–5.8, more particularly 5.4–5.6. It is preferred if the incontinence product maintains a skin-friendly pH value for at least two, and in particular at least three, urination events.

[0057] In an advantageous further development of the embodiments described above, the present invention also includes an arrangement of incontinence articles, wherein the arrangement comprises at least two, in particular at least three, further in particular at least four, further in particular at least five, further in particular at least six incontinence articles, wherein at least a first incontinence article and a second incontinence article of the arrangement differ in at least one feature selected from the group consisting of size, absorption capacity according to ISO 11948-1 (1996), and amount of pH regulating agent in g / m³. 2 Total amount of pH regulator per incontinence product, number of absorbent layers, differentiate

[0058] The total amount of pH regulator per incontinence product, which is particularly intended for use by adults, is preferably 0.2 to 3.0 g, more preferably 0.4 to 2.5 g, and more preferably 0.6 to 2.0 g.

[0059] Incontinence articles of a preferred arrangement differ from each other in the amount of pH regulator in g / m² or in the total amount of pH regulator per incontinence article or absorption capacity according to ISO 11948-1 (1996) if the first incontinence article has a respective value that is at least 20%, in particular at least 30%, further in particular at least 40%, further in particular at least 50%, further in particular at least 75%, further in particular at least 100% higher than the respective value of the second incontinence article.

[0060] An arrangement is formed by the meaningful presentation of the incontinence products belonging to the arrangement, in particular by the relationship or connection between the products. This is achieved either by presenting them in a common packaging unit and / or preferably by affixing markings to the incontinence products and / or their packaging and / or by presenting them in close proximity, either spatially or conceptually, in a way that clearly indicates their membership in an arrangement. The incontinence products forming the arrangement preferably originate from one and the same manufacturer.

[0061] The incontinence products forming an arrangement preferably bear the same product identification, such as brand names and / or sub-brand names. An arrangement of incontinence products of one form of a characteristic and incontinence products of a second form of a characteristic, such as one size and one size, is understood to include at least one representative of each and includes a plurality of incontinence products of one form of a characteristic and / or of incontinence products of a second form of a characteristic, or packages and packaging units containing such products.

[0062] Furthermore, the present invention also includes an arrangement of incontinence articles, wherein the arrangement comprises at least two, in particular at least three, further in particular at least four, further in particular at least five, further in particular at least six incontinence articles, wherein at least a first incontinence article and a second incontinence article of the arrangement are different incontinence articles selected from the group consisting of incontinence pads, open-type incontinence diapers with closure systems, closed-type incontinence diapers, and bed pads.

[0063] Further features, details, and advantages of the invention will become apparent from the attached claims and from the graphic representation and subsequent description of preferred embodiments of the invention and examples. The drawing shows:

[0064] Figure 1 schematic top view of an open-type incontinence diaper with fastening elements as an embodiment of an incontinence product according to the invention.

[0065] Figure 2a schematically shows a cross-section through an incontinence product with a storage layer made of SAP material, a fluid absorption layer, and a pH regulator arranged between them. Figure 2b schematically shows a cross-section through an incontinence product with two storage layers, SAP material, a fluid absorption layer, and a pH regulator arranged between them.

[0066] Figure 3 schematically shows the positions of measuring points for surface measurement of pH values ​​relative to a liquid absorption layer.

[0067] Figure 1 shows, not to scale, a schematic representation of an incontinence product according to the invention, designated in its entirety by reference numeral 17, by way of example an open-type incontinence diaper with closure elements in the so-called T-shape for adults. The incontinence diaper 17 comprises a main part (chassis) designated in its entirety by reference numeral 65, with an absorbent core 69 for absorbing body fluids. In this embodiment, the absorbent core 69 comprises at least one storage layer 70 containing SAP material (not shown in Figure 1) and a fluid absorption layer 71. The incontinence diaper 17 according to the invention contains a pH regulator 72, which is arranged essentially between the fluid absorption layer 71 and the at least one storage layer 70 of the absorbent core, as described in more detail in Figures 2a and 2b.The absorption body 69 is arranged between two flat materials, namely a topsheet 80 that is at least partially permeable to liquids and a backsheet 81 of the diaper main part 65 that is essentially impermeable to liquids.

[0068] The incontinence diaper 17 has a longitudinal direction 73 and a transverse direction 74, the latter corresponding to the user's hip circumference when the diaper is worn. The main part 65 comprises a front section 82 with front lateral longitudinal edges 83, a back section 64 with a first rear lateral longitudinal edge 66 and a second rear lateral longitudinal edge 67, and a crotch section 84 located between them. Adjacent to each longitudinal edge 85 of the crotch section 84, the main part 65 has an elasticized section, namely an elasticized leg opening section 86.In the case shown, these elasticized leg opening sections 86 are formed by elastic threads running between topsheet 80 and backsheet 81 and fixed to topsheet 80 and / or backsheet 81 in a pre-tensioned state, which are curved in an arc shape, thus being oriented at least with one component in the longitudinal direction 73 of the incontinence diaper 17.

[0069] In the T-shaped incontinence diaper 17, a first elastic diaper side panel 62 and a second elastic diaper side panel 63 are provided in the back area 64 of the main part 65 in the transverse direction 74 of the incontinence diaper 17. These extend laterally beyond the first rear lateral longitudinal edge 66 and are permanently attached to the back area 64 of the main part 65 in an overlap area 87 at the rear lateral longitudinal edges 66 and 67, respectively. No diaper side panels are provided in the front area 82.

[0070] In an alternative embodiment, the incontinence diaper can also be designed as an H-shaped incontinence diaper, in which case additional side panels are formed in the front area and preferably on both sides, as shown, for example, in W02005102241 A1. Another embodiment is a closed-type incontinence diaper, in which case a front and back section are preferably attached, respectively, and these are joined together at their respective lateral longitudinal edges in such a way that the incontinence diaper is closed in a ring shape in the direction of the hip circumference, as shown, for example, in W02013171068A1. As a further embodiment, the incontinence product 17 can be designed as a bed pad or incontinence pad.

[0071] The first elastic diaper side panel 62 and the second elastic diaper side panel 63 of the T-shaped incontinence diaper 17 each have at least one fastening element 44 in the area of ​​their end 88 that is free in the transverse direction 74 of the incontinence diaper 17. The fastening element 44 is designed in the form of a preferably rectangular flap and is folded inwards by the manufacturer. In the situation of use, the fastening element 44 can be opened, i.e., unfolded again, in order to put the incontinence diaper 17 on a user, whereby the first elastic diaper side panel 62 and the second elastic diaper side panel 63 are brought into overlap with the front area 82 of the main part 65 and the fastening elements 44 are detachably adhered to the side of the front area 82 of the main part 65 facing away from the user.Figures 2a and 2b show, schematically and not to scale, cross-sections of incontinence articles 18a and 18b, for example, an open-type incontinence diaper with fastening systems (as described in more detail in Figure 1), a closed-type incontinence diaper, an incontinence pad, or a bed pad. The incontinence articles 18a and 18b have a fluid-permeable topsheet 80, a substantially (i.e., in use) fluid-impermeable backsheet 81, and an absorbent core 76 arranged between them. The absorbent core 76 of the incontinence article 18a (Figure 2a) has a storage layer 70 with fiber material 70a, such as cellulose fibers or synthetic fibers, and SAP material 70b, a fluid-absorbing layer 71, and a pH regulator 72 arranged between them.The liquid absorption layer 71 forms a layer of the absorption body 76 directly facing the topsheet 80.

[0072] The storage layer 70 faces directly towards the backsheet and is essentially free of the pH regulator 72. The absorbent core of the incontinence product 18b (Figure 2b) additionally comprises a further layer, namely a layer 75 of the absorbent core 76 facing directly towards the backsheet 81, which consists essentially of fibrous material 70a, such as cellulose fibers or synthetic fibers, and is arranged between the storage layer 70 and the backsheet 81. The layer 75 facing directly towards the backsheet 81 is essentially free of the pH regulator 72.

[0073] In the embodiments shown in Figures 2a and 2b, the pH regulator 72 comprises particulate monosodium citrate, type “Fine Granular F3500” from Jungbunzlauer. This monosodium citrate has a particle size of 80 to 355 pm at 59% by weight and a purity of at least 99%. The amount of pH regulator 72 in this example is 30 g / m³. 2 .

[0074] In the cases shown, SAP material 70b is in particulate form. In a conceivable variant, the SAP material could be in fibrous, sheet, or foam form.

[0075] Figures 2a and 2b show the cross-section through the incontinence articles 18a and 18b, respectively, in the transverse direction 74. In the case of an incontinence diaper 17, for example, the cross-section is shown in the crotch area (reference numeral 84 in Figure 1, without showing the elasticized leg opening sections 86). The fluid absorption layer 71 only partially covers the storage layer 70 of the absorbent body 76 and, in this case, has a smaller extent than the storage layer 70 (Figure 2a) or the storage layer 70 and the layer 75 of the absorbent body 76 directly facing the backsheet 81 (Figure 2b) in the transverse direction 74 of the flat-lying incontinence article 18. Alternatively, the fluid absorption layer can completely cover the storage layer and / or the layer 75 of the absorbent body 76 directly facing the backsheet 81.

[0076] In this example (Figure 2b), the storage layer 70 is essentially the same length in the transverse direction 74 as the layer 75 of the absorption body 76 directly facing the backsheet 81. However, the storage layer 70 and the layer 75 of the absorption body 76 directly facing the backsheet 81 can also have different lengths.

[0077] Example 1: pH regulation by monosodium citrate or disodium citrate compared to citric acid

[0078] 1A: An adult incontinence diaper was manufactured with a pH regulator consisting of monosodium citrate (first incontinence diaper 1A, according to the invention). The incontinence diaper 1A comprised the following components in the arrangement shown:

[0079] Topsheet: SMS non-woven material, 12 g / m 2 , Type 3000063 from Avgol LTD Liquid absorption layer: Non-woven material carded and thermally bonded (“airthroughbonded”), Bico / PES, 40 g / m² 2, Dimensions 90x270 mm (0.0243 m 2 ), Type 11040WC0A from Berry pH regulator: 25 g / m 2 Monosodium citrate, purity >95%, non-hydrogenated, total amount per incontinence product 0.6 g, calculated total molar amount of monosodium citrate per incontinence product 0.003 mol, catalog number 21533 from Thermo Fisher Scientific

[0080] Storage layer: 21.5 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute; mixed with 13.5 g of particulate SAP material (type SXM 9791 from Evonik)

[0081] Layer of the absorbent core facing the backsheet: 34.8 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute

[0082] Backsheet: Non-woven film laminate, 18 g / m 2Hyfol PE soft Textile type 14202 from RKW 1B: Another adult incontinence diaper was manufactured with a pH regulator consisting of disodium citrate (second incontinence diaper 1B, for comparison, according to the invention). The incontinence diaper 1B had the following components in the specified arrangement:

[0083] Topsheet: SMS non-woven material, 12 g / m 2 , Type 3000063 from Avgol LTD Liquid absorption layer: Non-woven material carded and thermally bonded (“airthroughbonded”), Bico / PES, 40 g / m² 2 , Dimensions 90x270 mm (0.0243 m 2 ),

[0084] Type 11040WC0A from Berry pH regulator: 31 g / m 2 Disodium citrate, purity 99%, hydrate form (disodium hydrogen citrate sesquihydrate), total amount per incontinence product 0.75 g, calculated total molar amount of disodium citrate per incontinence product 0.003 mol, catalog number 25024 from Thermo Fisher Scientific

[0085] Storage layer: 21.5 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute; mixed with 13.5 g of particulate SAP material (type SXM 9791 from Evonik)

[0086] Layer of the absorbent core facing the backsheet: 34.8 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute

[0087] Backsheet: Non-woven film laminate, 18 g / m 2 Hyfol PE soft Textile type 14202 from RKW

[0088] 1C: Another adult incontinence diaper was produced with a pH regulator consisting of citric acid (third incontinence diaper 1C, for comparison, not according to the invention). Incontinence diaper 1C had the following components in the arrangement shown:

[0089] Topsheet: SMS non-woven material, 12 g / m 2 , Type 3000063 from Avgol LTD Liquid absorption layer: Non-woven material carded and thermally bonded (“airthroughbonded”), Bico / PES, 40 g / m² 2 , Dimensions 90x270 mm (0.0243 m2 ),

[0090] Type 11040WC0A from Berry pH regulator: 26 g / m 2 Citric acid, purity at least 99.5%, non-hydrogenated, total amount per incontinence product 0.625 g, calculated total molar amount of citric acid per incontinence product 0.003 mol, article number 471 A1F, "citric acid anhydrous pharm" from Barcelonesa. Absorption layer: 21.5 g cellulose fibers ("fluff"), type CoosAbsorb S from Resolute; mixed with 13.5 g particulate SAP material (type SXM 9791 from Evonik). Backsheet-facing layer of the absorbent core: 34.8 g cellulose fibers ("fluff"), type CoosAbsorb S from Resolute

[0091] Backsheet: Non-woven film laminate, 18 g / m 2 Hyfol PE soft Textile type 14202 from RKW

[0092] The pH regulator was positioned between the fluid absorption layer and the storage layer in the first 1A, second 1B and third incontinence diaper 1C.

[0093] To better compare the pH regulation in the first 1A, second 1B and third incontinence diaper 1C, the total amount of pH regulating agent per incontinence product was chosen so that there was an essentially the same total molar amount of 0.003 mol of the respective pH regulating agent per incontinence product (see Table 1).

[0094] Table 1: pH regulators used in Example 1

[0095] As described in more detail below in the section on the test method, three consecutive micturition events were simulated with a urine substitute fluid and the pH values ​​were measured on a respective outer top surface of the topsheet of the first, second and third.

[0096] The pH of the incontinence product was measured in the area of ​​the fluid absorption layer 71. Figure 3 shows the positions of four measuring points 3 relative to the fluid absorption layer 71 of the first, second, and third incontinence products (viewed from the topsheet). The transverse extent A of the fluid absorption layer 71 was 90 mm in each case. The longitudinal extent B of the fluid absorption layer 71 was 270 mm. The pH value was measured at all four measuring points 3, and an average value was calculated from the four measurements taken at each time point. This average value is shown in Table 3. Furthermore, a mean value and a corresponding standard deviation were calculated from the average pH values ​​obtained after each simulated voiding and are also shown in Table 3.The measuring points 3 were distributed along the longitudinal direction 73 of the respective liquid absorption layer such that the distance e between a measuring point 3 closest along the longitudinal direction 73 to a respective transverse edge 1 of the liquid absorption layer 71 and the respective transverse edge 1 closest along the longitudinal direction 73 was 45 mm. In this example, the distance d between two consecutive measuring points 3 along the longitudinal direction 73 was 60 mm.

[0097] The distance c between a measuring point 3 closest in transverse direction 74 to a respective longitudinal edge 2 of the respective liquid absorption layer 71 and the respective longitudinal edge 2 nearest in transverse direction 74 was 25 mm. The distance f between two consecutive measuring points 3 in transverse direction 74 was 40 mm in this example.

[0098] The respective fluid volumes of the three simulated micturitions can be found in Table 2.

[0099] Table 2: Volumes of urine replacement fluid used in Example 1

[0100] The pH values ​​measured at the four described measuring points at the different times can be found in Table 3.

[0101] Table 3: pH regulation, monosodium citrate and disodium citrate compared to citric acid; pH values ​​assigned to individual time points are averages from four measurements each.

[0102] The third incontinence diaper 1C with citric acid yielded pH values ​​of 4.0 to 4.5 after the first simulated urination, with a mean pH of 4.3 ± SD=0.2, significantly below the skin-friendly range. Only after the second and third simulated urinations, two and five hours after the start of the experiment, was a skin-friendly pH value in the range of 5.4 to 5.5 achieved (mean pH 5.4 ± SD=0.1 and pH 5.5 ± SD=0.1).

[0103] The second incontinence diaper 1B with disodium citrate already showed skin-friendly pH values ​​of pH 5.0 to 5.3 (mean pH 5.2 ± SD=0.1) after the first simulated micturition and only increased slightly after the second and third simulated micturitions (mean pH 5.6 ± SD=0.1 and pH 5.7 ± SD=0.1).

[0104] The first incontinence diaper 1A with monosodium citrate also maintained a relatively constant, skin-friendly pH value of 5.1 to 5.5 over three simulated voiding events, and in particular kept the pH value constant at 5.4 to 5.5 after the second and third simulated voiding events (mean values ​​pH 5.5 ± SD=0.1). It was particularly surprising that both the first 1A and the second

[0105] Incontinence diaper 1B showed an approximately similar and skin-friendly pH value after the first simulated voiding (mean pH 5.2 ± SD=0.1), but a significantly higher pH value than the third incontinence diaper 1C with citric acid (mean pH 4.3 ± SD=0.2), even though all three incontinence diapers contained essentially the same total molar amount of pH-regulating agent (0.003 mol each). Furthermore, it was surprising that the pH values ​​of both the first 1A and the second incontinence diaper 1B did not rise, or did not rise significantly, after the second and third simulated voiding compared to the pH values ​​of the incontinence diaper 1C with citric acid (mean values ​​in Table 3).

[0106] The first incontinence diaper 1A with monosodium citrate showed only slightly better pH regulation over the entire duration of the experiment than the second incontinence diaper 1B with disodium citrate, with essentially the same total molar amount of pH regulator (0.003 mol in each case). Compared to the hydrogenated disodium citrate used in this example, approximately 20% less pH regulator by weight can therefore be used when using monosodium citrate. Thus, in addition to the process-related advantages described above, the choice of pH regulator can also offer economic and logistical benefits.

[0107] Example 2: pH regulation by a pH regulator consisting of citric acid and trisodium citrate

[0108] 2A: An adult incontinence diaper was manufactured using a pH regulator known in the prior art (WO2012121932A1) consisting of a mixture of trisodium citrate and citric acid, wherein the mixing ratio was 6.2:1 (w / w) (fourth incontinence diaper 2A, for comparison, not according to the invention). The incontinence diaper 2A comprised the following components in the specified arrangement:

[0109] Topsheet: SMS non-woven material, 12 g / m 2 , Type 3000063 from Avgol LTD Liquid absorption layer: Non-woven material carded and thermally bonded (“airthroughbonded”), Bico / PES, 40 g / m² 2 , Dimensions 90x270 mm (0.0243 m 2 ), Type 11040WC0A from Berry pH regulator: 31 g / m 2 (Total amount per incontinence product 0.75 g) Trisodium citrate : Citric acid 6.2:1 (w / w)

[0110] Storage layer: 21.5 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute; mixed with 13.5 g of particulate SAP material (type SXM 9791 from Evonik)

[0111] Layer of the absorbent core facing the backsheet: 34.8 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute

[0112] Backsheet: Non-woven film laminate, 18 g / m 2 Hyfol PE soft Textile type 14202 from RKW 2B: An adult incontinence diaper was manufactured with a pH regulator known in the prior art (WO2012121932A1) consisting of a mixture of trisodium citrate and citric acid, wherein the mixing ratio was 7.2:1 (w / w) (fifth incontinence diaper 2B, for comparison, not according to the invention). The incontinence diaper 2B comprised the following components in the specified arrangement:

[0113] Topsheet: SMS non-woven material, 12 g / m 2, Type 3000063 from Avgol LTD Liquid absorption layer: Non-woven material carded and thermally bonded (“airthroughbonded”), Bico / PES, 40 g / m² 2 , Dimensions 90x270 mm (0.0243 m 2 ), Type 11040WC0A from Berry pH regulator: 31 g / m 2 (Total amount per incontinence product 0.75 g) Trisodium citrate : Citric acid 7.2:1 (w / w)

[0114] Storage layer: 21.5 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute; mixed with 13.5 g of particulate SAP material (type SXM 9791 from Evonik)

[0115] Layer of the absorbent core facing the backsheet: 34.8 g of cellulose fibers (“fluff”), type CoosAbsorb S from Resolute

[0116] Backsheet: Non-woven film laminate, 18 g / m 2 Hyfol PE soft Textile type 14202 from RKW

[0117] The trisodium citrate used in the fourth 2A and fifth 2B incontinence diapers had a purity of >99% and was in dihydrate form (VWR Chemicals article number 27833.363). The citric acid was in its non-hydrogenated form and had a purity of at least 99.5% (Barcelonesa article number 471 A1 F, "citric acid anhydrous pharm").

[0118] The pH regulator was positioned between the fluid absorption layer and the storage layer in the fourth 2A and fifth incontinence diaper 2B.

[0119] As described in more detail in relation to Example 1 and in the section on the test method, three consecutive voiding events were simulated with a urine substitute solution, and the pH values ​​were measured on the respective outer surface of the topsheet of the fourth and fifth incontinence products in the area of ​​the absorbent layer 71. Figure 3 shows the positions of the four measuring points 3 relative to the absorbent layer 71 of the fourth and fifth incontinence products (viewing the topsheet). The transverse extent A of the absorbent layer 71 was 90 mm in each case. The longitudinal extent B of the absorbent layer 71 was 270 mm. The pH value was measured at all four measuring points 3, and an average value was calculated from the four measurements taken at each time point, which is shown in Table 5.From the average pH values ​​obtained after each simulated micturition, a mean value and the corresponding standard deviation were calculated and also shown in Table 5. The measuring points 3 were distributed along the longitudinal direction 73 of the respective liquid absorption layer such that the distance e between a measuring point 3 closest along the longitudinal direction 73 to a respective transverse edge 1 of the liquid absorption layer 71 and the respective transverse edge 1 closest along the longitudinal direction 73 was 45 mm. In this example, the distance d between two consecutive measuring points 3 along the longitudinal direction 73 was 60 mm.

[0120] The distance c between a measuring point 3 closest in transverse direction 74 to a respective longitudinal edge 2 of the respective liquid absorption layer 71 and the respective longitudinal edge 2 nearest in transverse direction 74 was 25 mm. The distance f between two consecutive measuring points 3 in transverse direction 74 was 40 mm in this example.

[0121] The fluid volumes of the three simulated micturitions can be found in Table 4.

[0122] Table 4: Volumes of urine replacement fluid used in Example 2

[0123] The pH values ​​measured at the described measuring points 3 at the various times can be found in Table 5.

[0124] Table 5: pH regulation, pH regulator consisting of citric acid and trisodium citrate, pH values ​​assigned to individual time points are averages from four measurements each.

[0125] The fourth and fifth incontinence diapers, 2A and 2B, containing the known pH regulator consisting of a mixture of trisodium citrate and citric acid in various ratios, yielded pH values ​​of 5.5 to 5.7 after the first simulated voiding. After the second and third simulated voiding, the respective pH values ​​in the fourth and fifth incontinence diapers rose to relatively high values ​​of 5.7 to 5.9. Despite the different ratios of trisodium citrate and citric acid, the fourth and fifth incontinence diapers, 2A and 2B, exhibited approximately the same pH regulation, indicating that neither ratio offered an advantage over the other in this example.

[0126] In the combined analysis of examples 1 and 2, it becomes clear that the pH-regulating agent monosodium citrate of the first incontinence diaper 1A or disodium citrate of the second incontinence diaper 1B was superior to all other tested third 1C, fourth 2A and fifth incontinence diapers 2B, since the pH values ​​of the first 1A and second incontinence diaper 1B remained within the skin-friendly range across all three simulated micturitions, in particular the pH values ​​remained relatively constant within a narrow range, and furthermore, there was no significant drop in pH values ​​after the first micturition and no significant increase even over more than 5 hours with a total of three simulated micturitions.

[0127] Test method: pH value measurement on the surface of an incontinence product:

[0128] To perform a pH measurement on the surface of an incontinence product, particularly on the outer surface of the product's topsheet, a urine replacement solution is used. This solution is a 0.9% w / v solution of sodium chloride (NaCl) in distilled water, prepared according to ISO 11984-1 (1996) and adjusted to pH 6.8 with sodium hydroxide (NaOH). Such a solution has long been known in the field, and its preparation is a routine procedure.

[0129] The incontinence product to be tested is laid flat with the topsheet side facing upwards, unfolded completely if necessary and fixed to a base if necessary.

[0130] The test is performed according to ISO 11984-1 (1996) at a temperature of 23 °C ± 2 °C and a relative humidity of 50% ± 5%. The incontinence product to be tested and the urine replacement fluid are preconditioned according to ISO 11984-1 (1996).

[0131] To realistically simulate a usage situation and to monitor the pH development or the buffering effect of the pH regulator over a longer period of use with multiple urination events, three urination events are simulated over a five-hour period as described below. The incontinence product is loaded with a total volume of liquid corresponding to approximately 90% of its maximum absorption capacity.

[0132] The volumes of the first, second, and third simulated voidings should therefore be chosen so that the total volume of these two simulated voidings corresponds to approximately 90% of the maximum absorption capacity of the incontinence product. The volume of the first simulated voiding corresponds to 45% to 50% of the maximum absorption capacity of the incontinence product. The volume of each simulated voiding is essentially the same and corresponds to 20% to 22.5% of the maximum absorption capacity.

[0133] If the maximum absorption capacity of an incontinence product is not known, the maximum absorption capacity is determined in advance in accordance with ISO 11984-1 (1996) using a second comparable incontinence product, for example, an incontinence product of the same absorbency, size and type and, if necessary, taken from the same package as the incontinence product to be tested.

[0134] A volume of urine replacement solution corresponding to 50% of the maximum absorption capacity of the incontinence product is poured onto the dry incontinence product within 30 seconds to simulate an initial voiding event. The solution is poured in such a way that it lands in an area where, during a voiding event under normal use, the voiding fluid would land on the product. If this area is not clearly defined, the urine replacement solution should land in the center of the absorbent core, specifically along one of the core's transverse axes. If the incontinence product has a fluid absorption or distribution layer, the urine replacement solution is poured in the center of an area defined by this layer.

[0135] Two hours after the start of the first simulated micturition with the first volume of urine replacement solution, a second volume of urine replacement solution, which corresponds to 20% of the maximum absorption capacity of the incontinence product, is poured onto the incontinence product as described above to simulate a second micturition.

[0136] Five hours after the start of loading with the first volume of urine replacement solution, a third volume of urine replacement solution, which corresponds to 20% of the maximum absorption capacity of the incontinence product, is poured onto the incontinence product as described above to simulate a third micturition.

[0137] After each of the three simulated voiding events, the pH value is measured on the outer surface of the topsheet of the incontinence product 1, 3, 5, 10, 15, and 20 minutes after the end of the respective simulated voiding. For this purpose, the pH value is measured at four points spaced apart along the length and / or width of the flat, spread-out incontinence product, and an average of the four measured values ​​is calculated. If a fluid absorption or distribution layer is present, the measurements should be taken within the area formed by this layer. In any case, the measurement points must be located within an area covered by pH-regulating agent.

[0138] The measuring points should be spaced apart and, in particular, should not overlap. It is essential to ensure that the measuring points on the incontinence product are not too dry in order to obtain reliable results. Ideally, the positions of the four measuring points should be maintained for all measurements; however, it is also possible to vary the position of one or more measuring points, for example, if a measuring point is too dry at the time of a later measurement. This can occur, for instance, with incontinence products that have particularly low rewetting, especially 15 and / or 20 minutes after the respective simulated voiding. If at least two suitable measuring points are not available for a measurement at a given time, the measurement will only be evaluated at the other time points after the end of the respective simulated voiding.If only two or three measuring points are available for a measurement, an average value of the two or three measured values ​​must be calculated.

[0139] Due to the routine nature of such pH measurements in the field, it is easy for a specialist to assess whether a potential measuring point is too dry.

[0140] The measurement can generally be performed with any measuring device that, in the expert's opinion, is suitable for surface pH measurement. For example, the electrodes of models HL 14142 or HL 1413 from HANNA Instruments are suitable. The measuring device is calibrated according to the manufacturer's instructions before the measurement begins.

Claims

Patent claims 1. Incontinence product for the absorption of bodily excretions, comprising a topsheet that is at least partially permeable to liquid, a backsheet that is essentially impermeable to liquid and an absorbent body arranged between the topsheet and the backsheet, wherein the incontinence product comprises a pH regulator at least partially between the topsheet and the backsheet, characterized in that the pH regulator comprises monosodium citrate or disodium citrate.

2. Incontinence article according to claim 1, wherein the pH regulating agent comprises trisodium citrate.

3. Incontinence product according to claim 1, wherein the pH regulator consists of monosodium citrate.

4. Incontinence article according to claim 1, wherein the pH regulator consists of disodium citrate.

5. Incontinence articles according to one or more of claims 1 to 4, wherein the pH regulating agent is particulate.

6. Incontinence article according to claim 5, wherein at least 50 percent by weight of the pH regulating agent has a particle size of 10 to 2000 pm, in particular of 50 to 1200 pm, and further in particular of 80 to 800 pm.

7. Incontinence articles according to one or more of claims 1 to 6, wherein the amount of pH regulator is 10 to 100 g / m² 2 , especially 20 to 80 g / m² 2 , especially 25 to 60 g / m² 2 amounts.

8. Incontinence articles according to one or more of claims 1 to 7, wherein the absorbent body comprises at least one storage layer having a superabsorbent polymer (SAP).

9. Incontinence article according to claim 8, wherein the storage layer is substantially free of the pH regulating agent.

10. Incontinence article according to one or more of claims 1 to 9, wherein the incontinence article comprises a fluid absorption layer forming a layer of the absorbent body directly facing the topsheet.

11. Incontinence article according to claim 10, wherein the pH regulator is positioned substantially between the fluid absorption layer and an absorbent layer facing the backsheet.

12. Incontinence product according to one or more of claims 1 to 11, wherein the incontinence product maintains a skin-friendly pH value over at least two, in particular at least three, micturition events.

13. Incontinence article according to claim 12, wherein the pH value on a skin-facing upper surface of the incontinence article is a value of 4.8-6.5, in particular 5.0-6.2, further in particular 5.2-6.0, further in particular 5.3-5.8, further in particular 5.4-5.

6.

14. An arrangement of incontinence articles according to one or more of claims 1 to 13, wherein the arrangement comprises at least two, in particular at least three, further in particular at least four, further in particular at least five, further in particular at least six incontinence articles, wherein at least a first incontinence article and a second incontinence article of the arrangement differ in at least one feature selected from the group consisting of size, absorption capacity according to IS011948-1 (1996), amount of pH regulator in g / m 2 , Total amount of pH regulating agent per incontinence product, number of absorbent layers, differ.

15. An arrangement of incontinence articles according to one or more of claims 1 to 14, wherein the arrangement comprises at least two, in particular at least three, further in particular at least four, further in particular at least five, further in particular at least six incontinence articles, wherein at least a first incontinence article and a second incontinence article of the arrangement are different incontinence articles selected from the group consisting of incontinence pads, open-type incontinence diapers with closure systems, closed-type incontinence diapers, and bed pads.